Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants
| Description | HBvaxPRO 40micrograms/1ml vaccine suspension for injection vials (Merck Sharp & Dohme (UK) Ltd) |
| BNF code | 1404000G0BEACAG |
| Virtual Medicinal Product | Hepatitis B (rDNA) 40micrograms/1ml vaccine suspension for injection vials |
| Name | HBvaxPRO 40micrograms/1ml vaccine suspension for injection vials |
| Abbreviated name | HBvaxPRO 40micrograms/1ml vacc inj vials |
| Date of name applicability | 12 May 2006 |
| Previous name | HBvaxPRO 40micrograms/1ml suspension for injection vials |
| Supplier | Merck Sharp & Dohme (UK) Ltd |
| Current licensing authority | Medicines - MHRA/EMA |
| EMA additional monitoring | ✗ |
| Parallel import | ✗ |
| Restrictions on availability | None |
| Licensed Route | |
|---|---|
| Licenced route | Intramuscular |
| Licensed Route | |
| Licenced route | Subcutaneous |
| Actual Medicinal Product Packs | |
| HBvaxPRO 40micrograms/1ml vaccine suspension for injection vials (Merck Sharp & Dohme (UK) Ltd) 1 vial | |
dm+d data retrieved from TRUD: release NHSBSA_11.2.0_20241118000001, imported on 19th November 2024 at 03:53:26.